{"id":"W2902348306","doi":"10.1111/ajco.13059","title":"Prime time for immunotherapy in advanced urothelial cancer","year":2018,"lang":"en","type":"review","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Pembrolizumab; Carboplatin; Oncology; Internal medicine; Clinical trial; Chemotherapy; Disease; Cisplatin; Immunotherapy; Cancer; Intensive care medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002625898,0.0005600483,0.007224597,0.0003922952,0.00005066441,0.00001580249,0.0004556625,0.00130374,0.0007217655],"category_scores_gemma":[0.0008252143,0.0003780744,0.002523119,0.0003123584,0.0003380299,0.0001079015,0.00004259154,0.001492163,0.0001606336],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000755434,"about_ca_system_score_gemma":0.009737429,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001643017,"about_ca_topic_score_gemma":0.00001737858,"domain_scores_codex":[0.9931754,0.0007079555,0.004618569,0.0005435021,0.0003887359,0.000565866],"domain_scores_gemma":[0.9931852,0.002072549,0.003363538,0.0004925726,0.0005147053,0.0003713978],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00422841,0.001192526,0.0001570113,0.0009173813,0.001563841,0.0001896024,0.00005534006,1.492129e-7,0.000005102993,0.00000960669,0.005860115,0.9858209],"study_design_scores_gemma":[0.01251808,0.01301071,0.0001490465,0.007116407,0.002078021,0.0005420977,0.00002598663,0.000001798784,0.000007810004,0.0001525375,0.9641153,0.0002821599],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009621189,0.9864908,0.00006801769,0.0009403688,0.003825694,0.00218757,0.0001215396,0.00001746055,0.006252372],"genre_scores_gemma":[0.00005693485,0.9869514,0.002973367,0.0003394667,0.00484385,0.0002024003,0.00002795297,0.0001362543,0.004468375],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9855388,"threshold_uncertainty_score":0.9999928,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1308510256706974,"score_gpt":0.5175727264392097,"score_spread":0.3867217007685123,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}